Statins and PPARα Activation in Liver Cells
Author Information
Author(s): Makoto Seo, Ikuo Inoue, Masaaki Ikeda, Takanari Nakano, Seiichiro Takahashi, Shigehiro Katayama, Tsugikazu Komoda
Primary Institution: Saitama Medical University
Hypothesis
Statins increase PPARα mRNA expression and activation in HepG2 cells.
Conclusion
Statins enhance PPARα production and activation through increased promoter activity in liver cells.
Supporting Evidence
- Most statins increased PPARα mRNA expression in HepG2 cells after 24 hours.
- Six statins significantly increased PPARα promoter activity in a dose-dependent manner.
- Statins increased PPARα protein levels in the nuclear fraction of HepG2 cells.
- Some statins significantly activated the transcription of PPARα target genes.
Takeaway
Statins help a part of our body called PPARα work better, which is important for managing fats and sugars.
Methodology
The study examined the effects of seven statins on PPARα promoter activity, mRNA expression, and protein levels in HepG2 cells.
Limitations
The study primarily focused on HepG2 cells and may not fully represent effects in other cell types or in vivo.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website